Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pulse Biosciences Inc PLSE

Healthcare Medical Devices
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it... see more

Recent & Breaking News (NDAQ:PLSE)

ROSEN, A TOP RANKED FIRM, Encourages Pulse Biosciences, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important April 18 Deadline in Securities Class Action - PLSE

Newsfile March 24, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Pulse Biosciences, Inc. - PLSE

Newsfile March 23, 2022

PLSE Investors Have Opportunity to Lead Pulse Biosciences, Inc. Securities Fraud Lawsuit

PR Newswire March 23, 2022

ROSEN, A Top Ranked Law Firm, Encourages Pulse Biosciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - PLSE

Newsfile March 22, 2022

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Pulse Biosciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - PLSE

PR Newswire March 21, 2022

Pulse Biosciences Schedules Fourth Quarter and Full Year 2021 Financial Results Conference Call for March 31, 2022

Business Wire March 21, 2022

ROSEN, A LEADING LAW FIRM, Encourages Pulse Biosciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - PLSE

Newsfile March 18, 2022

ROSEN, Global Investor Counsel, Encourages Pulse Biosciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - PLSE

Newsfile March 17, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pulse Biosciences, Inc. - PLSE

PR Newswire March 16, 2022

PLSE Investors Have Opportunity to Lead Pulse Biosciences, Inc. Securities Fraud Lawsuit

PR Newswire March 15, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pulse Biosciences, Inc. - PLSE

Newsfile March 14, 2022

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Pulse Biosciences, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - PLSE

Newsfile March 14, 2022

ROSEN, A LEADING LAW FIRM, Encourages Pulse Biosciences, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - PLSE

PR Newswire March 13, 2022

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Pulse Biosciences, Inc. Investors With Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - PLSE

Newsfile March 12, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Pulse Biosciences, Inc. - PLSE

Newsfile March 10, 2022

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Pulse Biosciences, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - PLSE

Newsfile March 10, 2022

ROSEN, A TOP RANKED LAW FIRM, Encourages Pulse Biosciences, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - PLSE

Newsfile March 9, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pulse Biosciences, Inc. - PLSE

PR Newswire March 8, 2022

PLSE NOTICE: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Pulse Biosciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - PLSE

Newsfile March 7, 2022

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Pulse Biosciences, Inc. (PLSE) Investors

PR Newswire March 7, 2022